0000899243-23-000630.txt : 20230104
0000899243-23-000630.hdr.sgml : 20230104
20230104163515
ACCESSION NUMBER: 0000899243-23-000630
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230104
DATE AS OF CHANGE: 20230104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chiniara Ellen
CENTRAL INDEX KEY: 0001398764
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39460
FILM NUMBER: 23507085
MAIL ADDRESS:
STREET 1: 51 SAWYER ROAD, SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kymera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001815442
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812992166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 857-285-5314
MAIL ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-03
0
0001815442
Kymera Therapeutics, Inc.
KYMR
0001398764
Chiniara Ellen
C/O KYMERA THERAPEUTICS, INC.
200 ARSENAL YARDS BLVD. SUITE 230
WATERTOWN
MA
02472
0
1
0
0
Chief Legal Officer
Common Stock
2023-01-03
4
A
0
37500
0.00
A
37500
D
Stock Option (Right to Buy)
24.84
2023-01-03
4
A
0
225000
0.00
A
2033-01-02
Common Stock
225000
225000
D
Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following January 3, 2023, subject to the reporting person's continued employment through each vesting date.
25% of the shares underlying this stock option shall vest on January 3, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the reporting person's continued employment through each vesting date.
/s/ Bruce Jacobs, as Attorney-in-Fact
2023-01-04